February 24, 2026 16:30 ET | Source: Cardiff Oncology, Inc. Reported positive update from Phase 2 CRDF-004 trial in first-line…
February 20, 2026 17:16 ET | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…
2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed…
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology…
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology February 17, 2026 08:00 ET | Source:…
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits2 as of December 31, 2025Revenues of €4.5…
February 13, 2026 16:30 ET | Source: Natural Alternatives International Inc CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural…
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase…
50-year study of the US market and 20 years of foreign market data informs components of market value.NEW YORK, Feb.…
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and…